TY - JOUR
T1 - Fibroblast growth factor 13-mediated regulation of medium spiny neuron excitability and cocaine self-administration
AU - Dvorak, Nolan M.
AU - Di Re, Jessica
AU - Vasquez, Tileena E.S.
AU - Marosi, Mate
AU - Shah, Poonam
AU - Contreras, Yorkiris M.Mármol
AU - Bernabucci, Matteo
AU - Singh, Aditya K.
AU - Stallone, Jariatu
AU - Green, Thomas A.
AU - Laezza, Fernanda
N1 - Publisher Copyright:
Copyright © 2023 Dvorak, Di Re, Vasquez, Marosi, Shah, Contreras, Bernabucci, Singh, Stallone, Green and Laezza.
PY - 2023
Y1 - 2023
N2 - Cocaine use disorder (CUD) is a prevalent neuropsychiatric disorder with few existing treatments. Thus, there is an unmet need for the identification of new pharmacological targets for CUD. Previous studies using environmental enrichment versus isolation paradigms have found that the latter induces increased cocaine self-administration with correlative increases in the excitability of medium spiny neurons (MSN) of the nucleus accumbens shell (NAcSh). Expanding upon these findings, we sought in the present investigation to elucidate molecular determinants of these phenomena. To that end, we first employed a secondary transcriptomic analysis and found that cocaine self-administration differentially regulates mRNA for fibroblast growth factor 13 (FGF13), which codes for a prominent auxiliary protein of the voltage-gated Na+ (Nav) channel, in the NAcSh of environmentally enriched rats (i.e., resilient behavioral phenotype) compared to environmentally isolated rats (susceptible phenotype). Based upon this finding, we used in vivo genetic silencing to study the causal functional and behavioral consequences of knocking down FGF13 in the NAcSh. Functional studies revealed that knockdown of FGF13 in the NAcSh augmented excitability of MSNs by increasing the activity of Nav channels. These electrophysiological changes were concomitant with a decrease in cocaine demand elasticity (i.e., susceptible phenotype). Taken together, these data support FGF13 as being protective against cocaine self-administration, which positions it well as a pharmacological target for CUD.
AB - Cocaine use disorder (CUD) is a prevalent neuropsychiatric disorder with few existing treatments. Thus, there is an unmet need for the identification of new pharmacological targets for CUD. Previous studies using environmental enrichment versus isolation paradigms have found that the latter induces increased cocaine self-administration with correlative increases in the excitability of medium spiny neurons (MSN) of the nucleus accumbens shell (NAcSh). Expanding upon these findings, we sought in the present investigation to elucidate molecular determinants of these phenomena. To that end, we first employed a secondary transcriptomic analysis and found that cocaine self-administration differentially regulates mRNA for fibroblast growth factor 13 (FGF13), which codes for a prominent auxiliary protein of the voltage-gated Na+ (Nav) channel, in the NAcSh of environmentally enriched rats (i.e., resilient behavioral phenotype) compared to environmentally isolated rats (susceptible phenotype). Based upon this finding, we used in vivo genetic silencing to study the causal functional and behavioral consequences of knocking down FGF13 in the NAcSh. Functional studies revealed that knockdown of FGF13 in the NAcSh augmented excitability of MSNs by increasing the activity of Nav channels. These electrophysiological changes were concomitant with a decrease in cocaine demand elasticity (i.e., susceptible phenotype). Taken together, these data support FGF13 as being protective against cocaine self-administration, which positions it well as a pharmacological target for CUD.
KW - cocaine use disorder
KW - fibroblast growth factor 13
KW - medium spiny neurons
KW - nucleus accumbens shell
KW - voltage-gated Na channel
UR - http://www.scopus.com/inward/record.url?scp=85179842346&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85179842346&partnerID=8YFLogxK
U2 - 10.3389/fnins.2023.1294567
DO - 10.3389/fnins.2023.1294567
M3 - Article
AN - SCOPUS:85179842346
SN - 1662-4548
VL - 17
JO - Frontiers in Neuroscience
JF - Frontiers in Neuroscience
M1 - 1294567
ER -